Dr. Daniel J Efraim, PHARM.D. Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 300 Twinning Street, Bldg 760 42 Mdss/sgsap, Maxwell Afb, AL 36112 Phone: 334-953-6868 |
Tristan Eddy, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 Twining St, Maxwell Afb, AL 36112 Phone: 334-953-5317 Fax: 334-953-8607 |
J Calvin Anderson Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 Twining Street, Maxwell Afb, AL 36112 Phone: 334-285-4395 Fax: 334-953-8296 |
Dr. Christian Edward Banasky, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 42d Medical Group, 300 S. Twining St Bldg 760, Maxwell Afb, AL 36112 Phone: 334-953-3368 Fax: 334-953-8607 |
Andrew B Meadows Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 Twining Street, Maxwell Afb, AL 36112 Phone: 334-953-5143 Fax: 334-953-8296 |
Dr. Vicki R Olszewski, PHARMD Pharmacist - Ambulatory Care Medicare: Not Enrolled in Medicare Practice Location: 300 Twining St Bldg 760, Maxwell Afb, AL 36112 Phone: 334-953-5270 |
Katelyn Zeringue, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 Twining St Bldg 76042nd, Maxwell Afb, AL 36112 Phone: 334-953-5200 |
News Archive
Three scientists who led the 11-year quest to develop a groundbreaking HIV drug today received the 2010 Discoverers Award - the highest honor given to scientists by the Pharmaceutical Research and Manufacturers of America. The honorees are Tony Wood, Ph.D., Elna van der Ryst, M.D., Ph.D. and Manos Perros, Ph.D.
IBM is collaborating with the Thai Red Cross AIDS Research Center (TRCARC) to strengthen HIV prevention effort and to make Bangkok the world's first city to achieve "Zero New HIV Infections" by 2015.
Brain cell dysfunction in low oxygen is, surprisingly, caused by the very same responder system that is intended to be protective, according to a new published study by a team of researchers at the Case Western Reserve University School of Medicine.
New data released today by the European Centre for Disease Prevention and Control and the WHO Regional Office for Europe ahead of World TB Day show that new tuberculosis cases and deaths in the 53 countries of the WHO European Region declined each year by 4.3% and 8.5% respectively between 2011 and 2015.
arGEN-X, a biopharmaceutical company specialized in the discovery and development of highly differentiated human monoclonal antibody therapeutics, announced today the initiation of a Phase Ib first-in-man cancer study with ARGX-110, its first SIMPLE Antibody program to enter the clinic in just three years from initiation of discovery.
› Verified 1 days ago